This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2014
Title: Jolanta Polkowska: Innovator in Amyloid-Related Disease Treatment
Introduction
Jolanta Polkowska is a distinguished inventor based in Essen, Germany. She has made significant contributions to the field of biomedical research, particularly in the treatment of amyloid-related diseases. Her innovative work has garnered attention for its potential to improve therapeutic strategies.
Latest Patents
Polkowska holds a patent for her invention titled "Molecular tweezers for the treatment of amyloid-related diseases." This invention provides novel compositions designed to inhibit the aggregation of amyloid proteins. In various embodiments, the compositions comprise molecular tweezers that bind lysine and/or arginine, thereby inhibiting the aggregation of amyloidogenic proteins. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Jolanta has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Gal Bitan and Akila Shanmugam. Their collaborative efforts have further enhanced the impact of her research and innovations.
Conclusion
Jolanta Polkowska's work in developing molecular tweezers for amyloid-related diseases exemplifies her dedication to improving healthcare through innovation. Her contributions are paving the way for new therapeutic approaches in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile